Chronotherapy of methylprednisolone in pediatric liver transplanted recipients

Chronotherapy of methylprednisolone in pediatric liver transplanted recipients - Chronotherapy of methylprednisolone

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015793

Enrollment

170

Registered

2014-11-30

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After liver transplantation

Interventions

Dosing of methylprednisolone at morning Dosing of methylprednisolone at evening

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who received living-related liver transplantation 2. Patients who are less than 15 years old

Exclusion criteria

Exclusion criteria: 1. Patients who need an urgently transplantation because fulminant hepatitis 2. Judged inappropriate to participate in this study by a doctor

Design outcomes

Primary

Measure	Time frame
Ratio of acute rejection	—

Secondary

Measure	Time frame
Ratio of any adverce effects	—

Countries

Japan

Contacts

Public ContactKentaro Ushijima

Jichi Medical University Division of Clinical Pharmacology

ushijima-kentarou@umin.ac.jp0285-58-7388

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026